// App-Quantinova.ai

TCT-455 : Long-term (1 year) Pathological Result of Everolimus-eluting versus Sirolimus-eluting and Bare Metal Stents

Researchers

Presenter

  • Hiroyoshi Mori

Principal Investigators

  • Sho Torii

  • Kazuyuki Yahagi

  • Emanuel Harari

  • Robert Kutys

  • Maria Romero

  • Renu Virmani

  • Aloke Finn

Medical Centers

  • CVPath institute, North Bethesda, Maryland, United States

  • CVPath Institute, Rockville, Maryland, United States

  • CVPath Institute Inc.

  • CVPath Institute Inc.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Chronic total occlusion

  • Neoatherosclerosis

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved